Skip to main navigation Skip to search Skip to main content

Use of inflammatory markers to guide cancer treatment

  • S. J. Clarke
  • , W. Chua
  • , M. Moore
  • , S. Kao
  • , V. Phan
  • , C. Tan
  • , K. Charles
  • , D. C. McMillan

Research output: Contribution to journalArticlepeer-review

69 Citations (Scopus)

Abstract

Patient"related factors, especially markers of inflammatory response, are prognostic in many common solid cancers. Here we review how such markers, in particular the acute"phase proteins C"reactive protein and albumin and a differential white cell count, can predict treatment outcomes in cancer patients. The review examines the literature pertaining to surgery, chemotherapy, and radiotherapy and discusses how inflammatory markers might be incorporated into the planning and monitoring of cancer treatments.
Original languageEnglish
Pages (from-to)475-478
Number of pages4
JournalClinical Pharmacology and Therapeutics
Volume90
Issue number3
DOIs
Publication statusPublished - 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • biomarkers
  • cancer
  • treatment

Fingerprint

Dive into the research topics of 'Use of inflammatory markers to guide cancer treatment'. Together they form a unique fingerprint.

Cite this